These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 24896540)

  • 1. A prodrug strategy based on chitosan for efficient intracellular anticancer drug delivery.
    Chen C; Zhou JL; Han X; Song F; Wang XL; Wang YZ
    Nanotechnology; 2014 Jun; 25(25):255101. PubMed ID: 24896540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted anticancer prodrug with mesoporous silica nanoparticles as vehicles.
    Fan J; Fang G; Wang X; Zeng F; Xiang Y; Wu S
    Nanotechnology; 2011 Nov; 22(45):455102. PubMed ID: 22019849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disassembly of amphiphilic small molecular prodrug with fluorescence switch induced by pH and folic acid receptors for targeted delivery and controlled release.
    Xu Z; Shi X; Hou M; Xue P; Gao YE; Liu S; Kang Y
    Colloids Surf B Biointerfaces; 2017 Feb; 150():50-58. PubMed ID: 27883931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amphiphilic polycarbonate conjugates of doxorubicin with pH-sensitive hydrazone linker for controlled release.
    Jiang T; Li YM; Lv Y; Cheng YJ; He F; Zhuo RX
    Colloids Surf B Biointerfaces; 2013 Nov; 111():542-8. PubMed ID: 23893028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acetal-linked paclitaxel prodrug micellar nanoparticles as a versatile and potent platform for cancer therapy.
    Gu Y; Zhong Y; Meng F; Cheng R; Deng C; Zhong Z
    Biomacromolecules; 2013 Aug; 14(8):2772-80. PubMed ID: 23777504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stimuli-responsive PEGylated prodrugs for targeted doxorubicin delivery.
    Xu M; Qian J; Liu X; Liu T; Wang H
    Mater Sci Eng C Mater Biol Appl; 2015 May; 50():341-7. PubMed ID: 25746279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multifunctional Polymeric Prodrug with Simultaneous Conjugating Camptothecin and Doxorubicin for pH/Reduction Dual-Responsive Drug Delivery.
    Dong S; Sun Y; Liu J; Li L; He J; Zhang M; Ni P
    ACS Appl Mater Interfaces; 2019 Mar; 11(9):8740-8748. PubMed ID: 30693750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural gelatin capped mesoporous silica nanoparticles for intracellular acid-triggered drug delivery.
    Zou Z; He D; He X; Wang K; Yang X; Qing Z; Zhou Q
    Langmuir; 2013 Oct; 29(41):12804-10. PubMed ID: 24073830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A strategy for oral chemotherapy via dual pH-sensitive polyelectrolyte complex nanoparticles to achieve gastric survivability, intestinal permeability, hemodynamic stability and intracellular activity.
    Deng L; Dong H; Dong A; Zhang J
    Eur J Pharm Biopharm; 2015 Nov; 97(Pt A):107-17. PubMed ID: 26515259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rod-like cellulose nanocrystal/cis-aconityl-doxorubicin prodrug: A fluorescence-visible drug delivery system with enhanced cellular uptake and intracellular drug controlled release.
    Li N; Lu W; Yu J; Xiao Y; Liu S; Gan L; Huang J
    Mater Sci Eng C Mater Biol Appl; 2018 Oct; 91():179-189. PubMed ID: 30033244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Self-assembling doxorubicin-tocopherol succinate prodrug as a new drug delivery system: synthesis, characterization, and in vitro and in vivo anticancer activity.
    Duhem N; Danhier F; Pourcelle V; Schumers JM; Bertrand O; Leduff CS; Hoeppener S; Schubert US; Gohy JF; Marchand-Brynaert J; Préat V
    Bioconjug Chem; 2014 Jan; 25(1):72-81. PubMed ID: 24328289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluorescent Copolymer-Based Prodrug for pH-Triggered Intracellular Release of DOX.
    Jia X; Zhao X; Tian K; Zhou T; Li J; Zhang R; Liu P
    Biomacromolecules; 2015 Nov; 16(11):3624-31. PubMed ID: 26461275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A pH-responsive glycolipid-like nanocarrier for optimising the time-dependent distribution of free chemical drugs in focal cells.
    Cheng B; Lu B; Liu X; Meng T; Tan Y; Zhu Y; Liu N; Yuan H; Huang X; Hu F
    Int J Pharm; 2017 Apr; 522(1-2):210-221. PubMed ID: 28259679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. "AND" logic gate regulated pH and reduction dual-responsive prodrug nanoparticles for efficient intracellular anticancer drug delivery.
    Bai L; Wang XH; Song F; Wang XL; Wang YZ
    Chem Commun (Camb); 2015 Jan; 51(1):93-6. PubMed ID: 25383506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methotrexate-based amphiphilic prodrug nanoaggregates for co-administration of multiple therapeutics and synergistic cancer therapy.
    Hou M; Gao YE; Shi X; Bai S; Ma X; Li B; Xiao B; Xue P; Kang Y; Xu Z
    Acta Biomater; 2018 Sep; 77():228-239. PubMed ID: 30006314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acid-activatable prodrug nanogels for efficient intracellular doxorubicin release.
    Zhan F; Chen W; Wang Z; Lu W; Cheng R; Deng C; Meng F; Liu H; Zhong Z
    Biomacromolecules; 2011 Oct; 12(10):3612-20. PubMed ID: 21905663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Self-Assembling Doxorubicin Prodrug Forming Nanoparticles and Effectively Reversing Drug Resistance In Vitro and In Vivo.
    Mao X; Si J; Huang Q; Sun X; Zhang Q; Shen Y; Tang J; Liu X; Sui M
    Adv Healthc Mater; 2016 Oct; 5(19):2517-2527. PubMed ID: 27529558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor-targeting and pH-responsive nanoparticles from hyaluronic acid for the enhanced delivery of doxorubicin.
    Liao J; Zheng H; Fei Z; Lu B; Zheng H; Li D; Xiong X; Yi Y
    Int J Biol Macromol; 2018 Jul; 113():737-747. PubMed ID: 29505869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Imaging of doxorubicin release from theranostic macromolecular prodrugs via fluorescence resonance energy transfer.
    Krüger HR; Schütz I; Justies A; Licha K; Welker P; Haucke V; Calderón M
    J Control Release; 2014 Nov; 194():189-96. PubMed ID: 25176577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrated hollow mesoporous silica nanoparticles for target drug/siRNA co-delivery.
    Ma X; Zhao Y; Ng KW; Zhao Y
    Chemistry; 2013 Nov; 19(46):15593-603. PubMed ID: 24123533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.